/
/
ASH 2021: Meet Kyle Colvin - A Physician and Myeloma Patient
ASH 2021: Meet Kyle Colvin - A Physician and Myeloma Patient image
ASH 2021: Meet Kyle Colvin - A Physician and Myeloma Patient
Posted Dec 09, 2021

Kyle Colvin was used to treating patients in his Spokane, Washington practice, not being one himself.  Seven and a half years after his diagnosis, he realized the Hippocratic Oath he took as a young doctor had new meaning now that he was a patient too; it was a duty of sorts.

“As a physician, I figured I may have a unique perspective on the disease, as well as a knowledge base and the time to help patients understand the disease course and treatment options,” Kyle reasoned, “I figure that I should give back to those in need since my life has been incredibly fortunate, even with this disease.”

 

After being treated with Revlimid/Velcade/dex (RVd) followed by a transplant, during maintenance, he’s focused more on oral therapies because they fit into his lifestyle.  But along the way he’s experienced Kyprolis, Darzalex, the dreaded dexamethasone and selinexor.  “I only lasted for one dose of selinexor.”

All patients can understand his “selfish, but true” attitude going into ASH, “I’m most interested in relapsed/refractory treatment options as this is what I’m facing” but he’s also “interested in novel agents being moved to first line treatment."

“Physicians generally do not have the luxury of time when meeting with patients and, consequently, patients may not have their questions answered or even feel heard.  I figure that I should give back to those in need since my life has been incredibly fortunate, even with this disease.”

 

The obligation imposed by a Hippocratic Oath never ends for those who take it.

The author Greg Brozeit

about the author
Greg Brozeit

Greg Brozeit has been engaged in myeloma patient advocacy since 1998. He began working with the Myeloma Crowd in 2015. Prior to that, he consulted with Dr. Bart Barlogie at the University of Arkansas after working with the International Myeloma Foundation for 15 years, where he inaugurated the public policy advocacy program, patient support group outreach and IMF Europe, organizing more than 100 physician and patient education programs. He earned his BA in political science from Loyola University in New Orleans and lives in northeast Ohio.

More Myeloma News Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811